Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2009-02-13
2010-11-16
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S496000
Reexamination Certificate
active
07834005
ABSTRACT:
Disclosed are compounds of Formula Iwherein X, Y, R1-R7, T1, T2, Z, and p are as described herein; a pharmaceutical composition comprising a compound of Formula I and a carrier; a method of inhibiting growth of a cell, which method comprises administering in an amount effective to inhibit growth a compound of Formula I; a method of treating cancer in a mammal, which method comprises administering in an amount effective to treat cancer a compound of Formula I; a method of treating a viral, parasitic, or bacterial infection of a cell, which method comprises administering in an amount effective to treat a viral, parasitic, or bacterial infection a compound of Formula I; and a method of preparing a compound of Formula I as described herein.
REFERENCES:
patent: 4464467 (1984-08-01), Hatori et al.
patent: 4508647 (1985-04-01), Hatori et al.
patent: 2003/0120069 (2003-06-01), Thurston et al.
patent: 1 193 270 (2002-04-01), None
patent: 58180487 (1983-10-01), None
patent: WO 93/18045 (1993-09-01), None
patent: WO 00/12508 (2000-03-01), None
Alley et al.,Proc. Amer. Assoc. Cancer Res., 43, #315 (2002).
Arima et al.,J. Antibiotics, 25(8), 437-444 (1972).
Bose et al.,Tetrahedron, 48(4), 751-758 (1992).
Gregson et al.,Chem. Commun., 9, 797-798 (1999).
Gregson et al.,J. Med. Chem., 44(5), 737-748 (2001).
Gregson et al.,J. Med. Chem., 47(5), 1161-1174 (2004).
Hara et al.,J. Antibiotics, 41(5), 702-704 (1988).
Hartley et al.,Proc. Amer. Assoc. Cancer Res., 43, #2432 (2002).
Hochlowski et al.,J. Antibiotics, 40(2), 145-148 (1987).
Hurley et al.,Acc. Chem. Res., 19, 230-237 (1986).
Itoh et al.,J. Antibiotics, 41(9), 1281-1284 (1988).
Kohn,Antibiotics, 3, 3-11 (1975).
Konishi et al.,J. Antibiotics, 37(3), 200-206 (1984).
Kuminoto et al.,J. Antibiotics, 33(6), 665-667 (1980).
Langley et al.,J. Org. Chem., 52(1), 91-97 (1987).
Leber et al.,J. Am. Chem. Soc., 110(9), 2992-2993 (1988).
Leimgruber et al.,J. Am. Chem. Soc., 87(24), 5793-5795 (1965).
Mountzouris et al.,J. Med. Chem., 37(19), 3132-3140 (1994).
Sagnou et al.,Bioorg. Med. Chem. Lett., 10, 2083-2086 (2000).
Shimizu et al.,J. Antibiotics, 35(8), 972-978 (1982).
Smellie et al.,Br. J. Cancer., 70, 48-53 (1994).
Takeuchi et al.,J. Antibiotics, 29(1), 93-96 (1976).
Thurston et al.,Chem. Brit., 26, 767-772 (1990).
Thurston et al.,Chem. Rev., 94(2), 433-465 (1994).
Thurston et al.,J. Org. Chem., 61(23), 8141-8147 (1996).
Tsunakawa et al.,J. Antibiotics, 41, 1366-1373 (1988).
Turner et al., 37th Midwest Regional Meeting of the American Chemical Society, Abstract, Oct. 23-25 (2002).
Walton et al.,Cancer Chemother. Pharmacol., 38, 431-438 (1996).
PCT/US2004/035050 International Search Report, mailed Apr. 22, 2005.
Howard Philip W.
Hsiao Luke Y.
Liu Paul S.
Snader Kenneth M.
Thurston David E.
Kifle Bruck
Leydig , Voit & Mayer, Ltd.
Midwest Research Institute
Spirogen, Ltd.
Starks Associates, Inc.
LandOfFree
Pyrrolobenzodiazepine derivatives, compositions comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolobenzodiazepine derivatives, compositions comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolobenzodiazepine derivatives, compositions comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4221486